Azitra (AZTR) Cash from Operations (2022 - 2026)
Azitra (AZTR) posted Cash from Operations of 2477304.0 for Q1 2026, up 13.64% on a QoQ basis from 2868486.0 in Q4 2025, and up 19.35% year-over-year from 2075622.38 in Q1 2025.
Azitra (AZTR) Cash from Operations (2022 - 2026) Analysis & Trends
Azitra's Cash from Operations history runs 5 years deep, the most recent figure standing at 2477304.0 for Q1 2026.
- Quarterly Cash from Operations rose 19.35% year-over-year to 2477304.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10605542.0 (down 3.62% YoY) and the FY2025 annual result came in at 11200000.0, down 9.98% from the prior year.
- Cash from Operations was 2477304.0 for Q1 2026 at Azitra, up from 2868486.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1304348.0 in Q1 2023 and bottomed at 3071762.0 in Q1 2025.
- A 5-year average of 2365418.87 and a median of 2475584.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations tumbled 131.53% — and 2026, when it grew 19.35%.
- Azitra's Cash from Operations stood at 2172692.0 in 2022, then retreated by 16.87% to 2539207.0 in 2023, then retreated by 1.85% to 2586201.0 in 2024, then decreased by 10.92% to 2868486.0 in 2025, then increased by 13.64% to 2477304.0 in 2026.
- Business Quant data shows AZTR's Cash from Operations at 2477304.0 in Q1 2026, 2868486.0 in Q4 2025, and 2444716.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | -2.49 Mn |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 201.34 Mn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 1.43 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | 1.08 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 70.50 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | -354.17 Mn |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - | -2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.48 Mn |
| Mar 31, 2026 | -2.48 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.44 Mn |
| Sep 30, 2025 | -2.44 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Mar 31, 2025 | -3.07 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -2.10 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Mar 31, 2024 | -3.02 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |